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 Abstract 
  The aim of this study was to evaluate the usefulness of the screening questions in the French 
version of the Dementia Quality of Life (DQoL) questionnaire. To assess the psychometric prop-
erties of the French DQoL, 155 patients with mild-to-moderate dementia were recruited. Here, 
we compared the psychometric properties of the instrument between patients who passed the 
screening test (n = 109) and the whole study population (n = 155). The French DQoL version 
showed a good test-retest reliability at a 2-week interval (0.95   ^   intraclass correlation coeffi-
cients  ^  1.0), and an average internal consistency (0.58  ^  Cronbach’s     ^  0.87) for the 2 study 
groups. Significant differences were observed in the 2 groups for 4 dimensions of the DQoL re-
garding dementia severity (Cornell scale), and for 3 dimensions evaluating depression (MMSE). 
Convergent validity with the Duke Health Profile revealed many significant correlations be-
tween dimensions not only in the 109 patients, but also in the whole study population. Our 
study demonstrated that patients who failed the screening procedure nonetheless seemed to 
be able to answer the DQoL questionnaire, the whole study group showing acceptable psycho-
metric properties.    Copyright © 2011 S. Karger AG, Basel 
  Published online: April 6, 2011 
EXTRA
  Damien Jolly, Prof. 
This is an Open Access article licensed under the terms of the Creative Commons
Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable 
to the online version of the article only. Distribution for non-commercial purposes only.
  Clinical Research Coordination Unit, Robert Debré Hospital 
  University Hospital of Reims, Rue du Doyen Kochman 
  FR–51092 Reims Cedex (France) 
  Tel. +33 3 26 78 84 72, E-Mail djolly    @   chu-reims.fr 
www.karger.com/dee
 DOI:  10.1159/000326782 85
Dement Geriatr Cogn Disord Extra 2011;1:84–92
 DOI:  10.1159/000326782 
EXTRA
  Wolak et al.: Use of the Screening Test in the French DQoL 
www.karger.com/dee
  © 2011 S. Karger AG, Basel 
  Published online: April 6, 2011 
 Introduction 
 In the setting of dementia, it is important to understand the patients’ perception of their 
own health. Specific tools to evaluate health-related quality of life (QoL) in dementia have 
been developed. Previously, it was assumed that dementia patients cannot be assessed; how-
ever, evaluation of the psychometric qualities of available tools has proved that evaluation of 
health-related QoL is also possible in demented subjects.
    The Dementia QoL (DQoL) questionnaire is a specific tool to assess QoL in the context 
of mild-to-moderate dementia. It is one of the most frequently used assessment tools among 
those currently available. A special characteristic of the DQoL is that it starts with 3 screen-
ing questions to be answered before proceeding with the main questionnaire. These screen-
ing questions aim to verify whether or not the respondent is capable of understanding the 
instrument. If a patient has more than 1 incorrect answer, administration of the main ques-
tionnaire is considered impossible. The percentage of patients who failed the screening test 
was reported to be 4.0% in the initial validation  [1] . Our study aimed to describe the psycho-
metric properties of the transcultural adaptation of the DQoL into French   [2]  , using data 
from all patients, including those who failed and those who passed the screening test, respec-
tively.
  M e t h o d s  
  Description of the DQoL 
  The DQoL was developed by Brod et al.   [1]   in 1999. It was first validated in a sample of 
99 patients with mild-to-moderate dementia [Mini Mental State Examination (MMSE)  6 10]. 
The questionnaire is administered by an interviewer and takes approximately 10 min. The 
DQoL is composed of 29 items forming 5 groups: self-esteem (4 items), positive affect and 
humor (6 items), negative affect (11 items), feeling of belonging (3 items), and sense of esthet-
ics (5 items). Each item is scored on a 5-point scale.
    Psychometric Validation of the French Version 
 Study  Design 
  A multicenter cross-sectional study repeated at a 2-week interval between March 2006 
and November 2007 was performed in 6 French hospitals and 1 French-speaking Swiss hos-
pital. The Institutional Review Board of the University Hospital in Reims (France) approved 
the study. Informed consent was obtained from all patients and their caregivers after provid-
ing specific information on the study. Patients were free to refuse or opt out at any time with-
out any impact on subsequent care. The study was conducted in compliance with good clin-
ical and epidemiologic practice and the Declaration of Helsinki   [3]  .
  Study  Population 
  Patients were recruited from centers with a memory clinic or a geriatric ward. Inclusion 
criteria were age   6  65 years; dementia as defined by the DSM IV criteria and validated by a 
senior geriatrician; mild-to-moderate dementia as defined by an MMSE score   6 10;  being 
native French speakers; availability of a main caregiver able to complete the questionnaire, 
and living at home or in an institution. We defined 3 groups: firstly, patients who failed the 
screening test (i.e.   1  1 incorrect answer out of the 3 screening questions); secondly, patients 
who passed the screening test, and thirdly, the entire study population comprising both pa-
tients who passed and patients who failed the screening test.86
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  D a t a   C o l l e c t i o n  
  Data were entered into specific case report forms by trained interviewers. Sociodemo-
graphic variables recorded during the study were age, gender, marital status, place of resi-
dence, and level of education. The caregiver burden as determined by the caregiver burden 
scale of Zarit et al.   [4]   was also recorded.
  Cognitive deficit was assessed by Folstein’s  [5]  version of the MMSE and by clinical eval-
uation of dementia severity using Hughes’s   [6]   Clinical Dementia Rating scale (CDR). Two 
scales were used to evaluate functional autonomy: Katz’s  [7]  Activities of Daily Living (ADL) 
and Lawton’s   [8]   Instrumental Activities of Daily Living (IADL). Behavior was assessed by 
the Neuropsychiatric Inventory (NPI)   [9]   and Cornell Depression scale   [10]  .
    Comorbidities were measured with the Charlson index   [11]   adapted to the ICD-10 ver-
sion by Sundararajan et al.   [12]  , and QoL was evaluated with the specific instrument under 
study (DQoL) and with a generic instrument, namely the Duke Health Profile   [13]  .
  Statistical  Analysis 
  Feasibility and acceptability of the questionnaire were assessed by the rate of refusals to 
participate or withdrawals, and the rate of non-response. Ceiling and floor effects were cal-
culated. Discriminant validity of the DQoL was assessed in terms of severity of cognitive 
decline (in 2 subgroups, i.e. subjects with MMSE   !  18 vs.   6  18), and in terms of depression 
(in 2 subgroups, i.e. Cornell index   !  8 vs.   6  8). For these comparisons, Student’s t tests were 
used.
    Convergent validity was assessed by calculating correlations between the DQoL dimen-
sions and the Duke Health Profile, IADL, NPI, Cornell index, CDR, and MMSE using Spear-
man’s correlation coefficient.
    Test-retest reliability at a 2-week interval was assessed using the intraclass correlation 
coefficient (ICC). An ICC  1 0.8 indicates good test-retest reliability  [14] . Internal consistency 
of the DQoL was tested using Cronbach’s    coefficient. The threshold for acceptable reliabil-
ity was set at       6   0.7   [14] .
    For all statistical tests, a p value   !  0.05 was considered statistically significant. Analyses 
were performed using SAS software (version 9.0; SAS Institute Inc., Cary, N.C., USA).
  R e s u l t s  
 Patient  Characteristics 
  The total population included 155 patients, of whom 46 (29.7%) answered more than 1 
of the prerequisite screening questions incorrectly     (  table 1  )    . The remaining 109 patients 
passed the screening test and were included in the analysis of the psychometric properties of 
the French version of the DQoL.
    Instrument Acceptability, Floor and Ceiling Effect  
  There were no refusals to participate and no withdrawals from the study. No floor or 
ceiling  effect  was  observed    ( table 2 )  .
  Discriminant  Validity   
  In the group of 46 patients who failed the screening test, discriminant validity was low 
due to lack of power     (  table 3  )    . However, when the group of 109 patients who passed the 
screening test and completed the questionnaire was compared to the overall population of 
155, a good level of discriminant validity was observed in each group. We obtained 4 sig-
nificant differences between dimension scores for the MMSE subgroups (threshold   6 18): 87
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self-esteem, positive affect/humor, feeling of belonging, and sense of esthetics. We also ob-
served 3 significant differences between dimension scores for the Cornell scale subgroups 
(threshold   6  8): self-esteem, positive affect/humor, and negative affect.
  C o n v e r g e n t   Va l i d i t y  
  For the related measures (IADL, NPI, Cornell index, CDR, and MMSE), analysis of the 
whole study population (n = 155) revealed 3 additional significant correlations when com-
pared to the subgroup of 109 patients who passed the screening test (MMSE self-esteem: p  !  
0.05; MMSE sense of esthetics: p   !   0.05; CDR positive affect/humor: p   ^   0.01), whereas 1 
correlation that was significant in the subgroup of 109 patients (CDR feeling of belonging:
p   !   0.05) was no longer significant in the analysis of all 155 patients (  table 4  ).
    When we compared the Duke Health Profile and the DQoL (  table 5  ), we noticed that all 
the dimensions of the Duke Health Profile were significantly linked with at least 1 DQoL 
dimension for the groups of 109 and 155 patients, with similar levels of correlation.
  R e l i a b i l i t y      
  In the group of 109 patients, ICCs were between 0.95 and 1.00, showing good reliability 
(  table 6  ). For the 46 patients who failed the screening test and the overall population of 155 
patients, ICC had almost the same values (0.96–1.00).
Table 1.   Patient characteristics
Whole population 
(n = 155)
Patients who passed the
screening procedure 
(n = 109)1
Patients who failed the
screening procedure 
(n = 46)
Comparison 
between the 2   
subgroups
n% n% n% p
Female gender 98 63.2 68 62.4 30 65.2 0.86
Type of dementia 0.52
Alzheimer’s disease 122 78.7 84 77.1 38 82.6
Other dementia 33 21.3 25 22.9 8 17.4
Cornell scale 0.19
<8 121 79.1 82 75.9 39 86.7
≥8 32 20.1 26 24.1 6 13.3
Zarit scale 0.84
<21 50 40.7 36 40.0 14 42.4
≥21 73 59.3 54 60.0 19 57.6
CDR 0.01
0.5 41 26.6 36 33.3 5 10.9
1 68 44.2 45 41.7 23 50.0
2 41 26.6 26 24.1 15 32.6
3 4 2.6 1 0.9 3 6.5
n mean 8 SD n mean 8 SD n mean 8 SD p
Age, years 155 81.886.0 109 81.186.1 46 83.385.4 0.04
MMSE 155 20.884.4 109 21.284.3 46 19.984.4 0.09
ADL 153 4.981.4 108 5.181.3 45 4.581.4 0.01
IADL2 152 3.582.3 107 3.982.4 45 2.481.6 <0.001
NPI, global score 146 13.7811.6 104 14.0811.2 42 12.9812.6 0.59
Charlson index 155 2.181.2 109 2.181.3 46 2.081.0 0.52
1 M  ore than 1 exact answer in the first form. 2 IADL by PAQUID (4 items).88
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  The group of 109 patients showed good internal consistency (Cronbach’s    between 0.70 
and 0.87). For all 155 patients, Cronbach’s      varied from 0.69 to 0.87. Two dimensions (self-
esteem and feeling of belonging) were   !  0.70, indicating moderate internal consistency. For 
the group of 46 patients, Cronbach’s      varied from 0.58 to 0.87, with a value   !  0.70 in only 1 
dimension, namely self-esteem.
Table 2. Instrument acceptability, floor and ceiling effects
Dimension Items
n
Whole population (n = 155) Patients who passed the
screening procedure (n = 109)
Patients who failed the
screening procedure (n = 46)
n mean
8 SD
floor
effect, %
ceiling
effect, %
n mean
8SD
floor
effect, %
ceiling
effect, %
n mean
8 SD
floor
effect, %
ceiling
effect, %
Self-esteem 4 150 3.380.8 0.7 2.7 108 3.480.8 0.9 3.7 42 3.280.7 2.4 2.4
Positive affect/
humor 6 152 3.580.8 0.7 1.3 109 3.680.8 0.9 1.8 43 3.380.8 2.3 4.6
Negative affect 11 152 2.480.8 2.6 0.7 109 2.480.8 2.7 0.9 43 2.380.7 2.3 2.3
Feeling of 
belonging 3 149 3.580.9 1.3 4.0 108 3.680.9 0.9 5.6 41 3.480.9 2.4 4.9
Sense of esthetics 5 147 3.380.8 0.7 1.4  106 3.380.8 0.9 0.9  41 3.080.8 2.4 2.4
Table 3.   Discriminant validity (Student’s t test)
MMSE (mean 8 SD) C  ornell scale (mean 8 SD)
<18 ≥18 p <8 ≥8 p
Whole population (n = 155)
Total 31 124 121 32
Self-esteem 3.080.8 3.480.8 ≤0.01 3.480.8 2.980.8 ≤0.001
Positive affect/humor 3.081.0 3.780.7 ≤0.001 3.680.8 3.180.9 ≤0.01
Negative affect 2.380.9 2.480.7 2.280.7 3.080.8 ≤0.001
Feeling of belonging 3.081.0 3.680.8 ≤0.001 3.680.8 3.381.0
Sense of esthetics 2.980.8 3.480.8 ≤0.01 3.380.8 3.180.9
Patients who passed the screening procedure (n = 109)
Total 20 89 82 26
Self-esteem 3.081.0 3.580.7 ≤0.01 3.680.7 2.980.8 ≤0.001
Positive affect/humor 3.081.1 3.780.7 ≤0.01 3.780.7 3.281.0 ≤0.01
Negative affect 2.581.0 2.580.7 2.380.7 3.180.8 ≤0.001
Feeling of belonging 3.080.9 3.780.8 ≤0.001 3.680.8 3.380.9
Sense of esthetics 2.980.9 3.480.8 <0.05 3.380.8 3.280.9
Patients who failed the screening procedure (n = 46)
Total 11 35 39 6
Self-esteem 3.180.5 3.280.8 3.280.7 2.980.4
Positive affect/humor 3.180.8 3.480.8 3.480.8 2.980.7
Negative affect 2.180.6 2.380.7 2.280.7 2.780.6
Feeling of belonging 3.281.1 3.580.8 3.480.8 3.081.2
Sense of esthetics 2.980.7 3.380.9 3.380.8 2.580.589
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  Discussion 
  Our study showed that subjects with mild-to-moderate dementia who passed or failed 
the screening procedure nonetheless seemed to be able to answer the DQoL questionnaire, 
which proved to be able to reveal interesting psychometric properties.
    To evaluate the objective status of patients with dementia, physicians usually use spe-
cific tools such as CDR, MMSE or ADAS-cog for cognitive status, NPI or Cornell scale for 
behavior, and ADL or IADL for autonomy. It is virtually always possible to perform an eval-
uation using these tools. However, these objective evaluations do not provide information on 
the patients’ own perception of their disease. This complementary field of subjective evalu-
ation, such as self-reported QoL evaluation, is increasingly considered to be as important as 
objective evaluation.
  Among the tools available to measure specific QoL in the context of dementia, the DQoL 
presents several advantages; it can, for example, be used in any type of dementia, it is com-
pleted by the patient, and it has different scores, a global score and a score for each dimen-
sion. Furthermore, it contains one original dimension, i.e. sense of esthetics. However, it also 
possesses a screening procedure, and in theory, if patients fail the screening test, they are 
excluded. This principle of exclusion might be too restrictive in the light of our results. In-
deed, some patients may truly be unable to answer any questions, so it is logical to exclude 
them. However, it is equally important that the tool does not exclude too many patients. 
Geriatricians and neurologists need available tools, such as the DQoL, in order to take self-
reported QoL into account in their daily practice when evaluating subjects with dementia 
and measuring effects of prescribed care or of re-education. In our study, 29.7% of the pa-
Table 4.   Convergent validity (Spearman’s correlations with related measures)
Self-esteem Positive
affect/humor
Negative
affect
Feeling
of belonging
Sense
of esthetics
Whole population (n = 155)
IADL 0.19* 0.07 0.25** 0.09 0.07
NPI –0.11 –0.10 0.23** 0.10 –0.01
Cornell –0.27*** –0.26*** 0.36*** –0.12 –0.18*
CDR –0.26** –0.22** –0.02 –0.13 –0.17*
MMSE 0.18* 0.21** 0.02 0.15 0.17*
Patients who passed the screening procedure (n = 109)
IADL 0.21* –0.01 0.21* 0.14 0.06
NPI –0.18 –0.16 0.27** 0.00 –0.04
Cornell –0.34*** –0.31*** 0.40*** –0.18 –0.26**
CDR –0.27** –0.18 0.05 –0.20* –0.22*
MMSE 0.19 0.21* 0.04 0.18 0.16
Patients who failed the screening procedure (n = 46)
IADL 0.02 0.19 0.32* –0.15 0.11
NPI –0.02 –0.03 0.08 0.31 0.02
Cornell –0.22 –0.24 0.23 –0.05 0.02
CDR –0.09 –0.18 –0.10 0.17 0.01
MMSE 0.11 0.15 –0.07 0.04 0.16
*   p < 0.05; ** p ≤ 0.01; *** p ≤ 0.001.90
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tients included had actually failed the screening test. If the exclusion criterion had been ap-
plied as recommended, the reliability of the questionnaire would have been considerably 
diminished. Other specific tools like the QoL-AD   [15]   or the DEMQOL   [16]   do not present 
this type of limitation. Previous studies recommended to select patients with an MMSE score 
  6  10. Our results showed that the psychometric properties (test-retest, internal consistency, 
and convergent and discriminant validity) were not much different whether patients who 
failed the screening test were included into the analysis or not. Nevertheless, these psycho-
metric properties could not be accurately investigated because of the small sample size of the 
subgroup of 46 patients (lack of power). Accordingly, we suggest that the 3 screening ques-
tions could be used as a training step. Thus, all patients with mild-to-moderate dementia 
could be evaluated with the DQoL, although results of patients who did not pass the screen-
ing test should be interpreted with caution.
 
Table 6.   Reliability
Dimension Test-retest reliability1 I nternal  consistency2
n = 155 n = 109 n = 46 n = 155 n = 109 n = 46
Self-esteem 0.98 0.97 0.99 0.69 0.72 0.58
Positive affect/humor  0.99 0.99 0.98 0.84 0.85 0.79
Negative affect 1.00 1.00 1.00 0.87 0.87 0.87
Feeling of belonging 0.96 0.95 0.96 0.69 0.70 0.70
Sense of esthetics 0.97 0.96 0.99 0.74 0.75 0.72
1   ICC. 2 Cronbach’s .
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